Replies to post #180485 on Biotech Values

[jq1234]

Obviously many issues are touched by inversion, I only focus on drug companies in my post because pricing model is different from other industries - US consumers pay competitive if not lower price in most industries except drugs vs other developed countries.

The other issues that really gets to me is corporate governance issues. IMO paying executives' tax liabilities is much worse than inversion itself - I don't have problem with inversion in general term because at least you can argue inversion is for ALL shareholders. Among things I want change the most in US is corporate governance!

[biomaven0]

>>- allow competitive bidding of prices for drugs;

This to me is the obvious step - use the free market as your friend.

On the inversion issue, I expect to see things heat up if Walmart goes this route.

Pretty easy in concept to change the tax code to prevent inversions, although obviously the details are very tricky. They already tightened the rules once, no reason (except political) they can't tighten again - for example, they could require majority foreign ownership to move domicile.

Peter